HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

Laetrilo (amigdalina) (PDQ®)–Versión para pacientes

laetrile  complementary or alternative medicine procedure 

Resumen de información revisada por expertos sobre el uso del laetrilo (amigdalina) como tratamiento para personas con cáncer.

Preview   0 Users liked this content.
NCI

Cardo mariano (PDQ®)–Versión para profesionales de salud

complementary or alternative medicine procedure  silymarin 

Resumen de información revisada por expertos sobre el uso del cardo mariano como tratamiento para personas con cáncer.

Preview   0 Users liked this content.
NCI

Cardo mariano (PDQ®)–Versión para pacientes

complementary or alternative medicine procedure  silymarin 

Resumen de información revisada por expertos sobre el uso del cardo mariano como tratamiento para personas con cáncer.

Preview   0 Users liked this content.
NCI

Milk Thistle (PDQ®)–Patient Version

milk  patient  version  thistle  complementary or alternative medicine procedure  silymarin 

Milk thistle is available in the United States as a dietary supplement and small studies have been done in several cancers. The U.S. Food and Drug Administration has not approved milk thistle as a treatment for cancer or other medical conditions. Learn more in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

Milk Thistle (PDQ®)–Health Professional Version

health  milk  version  professional  thistle  complementary or alternative medicine procedure  silymarin 

Milk thistle is available in the United States as a dietary supplement. Human clinical trials have investigated milk thistle in hepatitis or cirrhosis, although small studies have been reported in some cancers. Get detailed information on studies of milk thistle in cancer in this clinician summary.

Preview   0 Users liked this content.